No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with ST-segment⇓elevation myocardial infarction undergoing primary percutaneous coronary intervention

Authors
Koul S.1, 8 , Gustav Smith J.1, 8 , Götberg M.1, 8 , Erlinge D.1, 8 , Omerovic E.2 , Redfors B.2 , Alfredsson J. 3, 4 , Venetsanos D. 3, 4 , Persson J.5 , Jensen J.6 , Lagerqvist B.7 , James S.7
Number of issue
3
Language
English
Pages
e005528
Status
Published
Volume
11
Year
2018
Organizations
  • 1 Department of Clinical Sciences|Skane University Hospital Lund|Lund University
  • 2 Department of Cardiology|Skane University Hospital|Lund University
  • 3 Department of Cardiology|Sahlgrenska University Hospital
  • 4 Department of Cardiology
  • 5 Department of Medical and Health Sciences|Linköping University
  • 6 Division of Cardiovascular Medicine|Department of Clinical Sciences|Danderyd University Hospital
  • 7 Department of Medicine|Capio Saint Göran Hospital|Karolinska Institute
  • 8 Uppsala Clinical Research Institute|Uppsala University
Date of creation
07.11.2019
Date of change
07.11.2019
Short link
https://repository.rudn.ru/en/records/article/record/50622/
Share

Other records

Зырянов С.К., Чеберда А.Е., Белоусов Д.Ю.
Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 27. 2018. P. 91-97
Alberts A.R., Bokhorst L.P., Drost F.J.H., Schröder F.H., Bangma C.H., Roobol M.J., Schoots I.G., Krestin G.P., Dwarkasing R.S., Van Leenders G.J., Barentsz J.O.
European Urology. Elsevier Science Publishing Company, Inc.. Vol. 73. 2018. P. 353-360